1H-2-Benzoxacyclotetradecin-1,7(8H)-dione,3,4,5,6,9,10-hexahydro-16-hydroxy-3-methyl-14-(sulfooxy)-, (3S,11E)- (132505-04-5)

Identification
Name:	1H-2-Benzoxacyclotetradecin-1,7(8H)-dione,3,4,5,6,9,10-hexahydro-16-hydroxy-3-methyl-14-(sulfooxy)-, (3S,11E)-
Synonyms:	1H-2-Benzoxacyclotetradecin-1,7(8H)-dione,3,4,5,6,9,10-hexahydro-16-hydroxy-3-methyl-14-(sulfooxy)-, [S-(E)]-;Zearalenone 4-sulfate
CAS:	132505-04-5
Molecular Formula:	C18H22 O8 S
Molecular Weight:	0
InChI:	InChI=1/C18H22O8S/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(26-27(22,23)24)11-16(20)17(13)18(21)25-12/h3,7,10-12,20H,2,4-6,8-9H2,1H3,(H,22,23,24)/b7-3-/t12-/m0/s1
Molecular Structure:
Properties
Flash Point:	°C
Boiling Point:	°Cat760mmHg
Density:	1.328g/cm³
Refractive index:	1.551
Flash Point:	°C
Safety Data

Other Product

1H-2-Benzoxacyclotetradecin-1,7(8H)-dione,14-(b-D-glucopyranosyloxy)-3,4,5,6,9,10-hexahydro-16-hydroxy-3-methyl-,(3S,11E)-
(3S,11E)-3,4,5,6,9,10-Hexahydro-14-methoxy-3-methyl-16-(trimethylsilyl)oxy-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
1H-2-Benzoxacyclotetradecin-1,7(8H)-dione,3,- 4,5,6,9,10-hexahydro-8,9,16-trihydroxy-14- methoxy-3-methyl-,(3S,8S,9S,11E)-
(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-3-methyl-5,14,16-tris(trimethylsilyloxy)-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
[3S,5R,11E,(-)]-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
(3S,11E)-3,4,5,6,9,10-Hexahydro-3-methyl-14,16-bis[(trimethylsilyl)oxy]-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 14-(ethylamino)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-3,4-dimethyl-, (3S,4R,5Z,8S,9S,11E)-
1H-2-Benzoxacyclotetradecin-1-one,7-(acetyloxy)-3,4,5,6,7,8,9,10-octahydro-14,16-dihydroxy-3-methyl-,[3S-(3R*,7S*,11E)]- (9CI)
1/C12H16BrIO2/c1-3-5-15-11-8-10(14)12(7-9(11)13)16-6-4-2/h7-8H,3-6H2,1-2H
1H-2-Benzoxacyclotetradecin-1-one,3,4,5,6,7,8,9,10-octahydro-7,14,16-trihydroxy-3-methyl-, (3S,7R,11E)-
1H-2-Benzoxacyclotetradecin-1-one,3,4,5,6,7,8,9,10-octahydro-7,14,16-trihydroxy-3-methyl-, (3S,7S,11E)-
(3S,7R,11E)-7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecin-1-one
1H-2-Benzoxacyclotetradecin-1,7(8H)-dione,3,4,5,6,9,10,11,12-octahydro-14,16-dihydroxy-3-methyl-, (3S)-
1H-2-Benzoxacyclotetradecin-1,7(8H)-dione,3,4,5,6,9,10-hexahydro-3-methyl-14,16-bis[(trimethylsilyl)oxy]-, (E)- (9CI)
(E)-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
(S-(Z))-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
1H-2-Benzoxacyclotetradecin-1,7(8H)-dione,3,4,5,6,9,10,11,12-octahydro-14,16-dimethoxy-3-methyl-, 7-(2-methylhydrazone)
1H-2-Benzoxacyclotetradecin-13-carboxaldehyde,3,4,5,6,7,8,9,10-octahydro-14,16-dihydroxy-3-methyl-1,7-dioxo-, (3S,11E)-
(3S,5E,7R,8S,11E)-7,8,14,16-Tetrahydroxy-3-methyl-3,4,7,8,9,10-he xahydro-1H-2-benzoxacyclotetradecin-1-one